Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 378, P. 460 - 475
Published: Dec. 21, 2024
Language: Английский
Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 378, P. 460 - 475
Published: Dec. 21, 2024
Language: Английский
Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 98, P. 105913 - 105913
Published: June 26, 2024
Language: Английский
Citations
5Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(8), P. 972 - 972
Published: July 23, 2024
Cancer remains a highly lethal disease globally. The approach centered on REDOX-targeted mitochondrial therapy for cancer has displayed notable benefits. Plant polyphenols exhibit strong REDOX and anticancer properties, particularly by affecting function, yet their structural instability low bioavailability hinder utility. To overcome this challenge, researchers have utilized the inherent physical chemical characteristics of derivatives to develop innovative nanomedicines targeting mitochondria. This review examines construction strategies properties various types polyphenol-based biological nanomedicine regulating mitochondria in recent years, such as polyphenol self-assembly, metal–phenol network, polyphenol–protein, polyphenol–hydrogel, polyphenol–chitosan, polyphenol–liposome. These polyphenolic incorporate enhanced features improved solubility, efficient photothermal conversion capability, regulation homeostasis, ion adsorption through diverse strategies. focus is how these promote ROS production mechanism inhibit cancer. Furthermore, it delves into benefits applications treatments, well challenges future research.
Language: Английский
Citations
4International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 140442 - 140442
Published: Jan. 1, 2025
Language: Английский
Citations
0Journal of Controlled Release, Journal Year: 2025, Volume and Issue: unknown, P. 113704 - 113704
Published: April 1, 2025
Language: Английский
Citations
0International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 283, P. 137707 - 137707
Published: Nov. 18, 2024
Language: Английский
Citations
3Small, Journal Year: 2024, Volume and Issue: 20(46)
Published: Aug. 7, 2024
This paper introduces catheter-directed intravascular casting hydrogels for transarterial chemo/starvation/chemodynamic embolization (TACSCE) therapy of hepatocellular carcinoma (HCC). Comprising Mn ion-crosslinked hyaluronic acid-dopamine (HD) with glucose oxidase (for decomposition to H
Language: Английский
Citations
2Journal of Translational Medicine, Journal Year: 2024, Volume and Issue: 22(1)
Published: Oct. 27, 2024
Gastrointestinal tumors are the main causes of death among patients. These mainly diagnosed in advanced stages and their response to therapy is unfavorable. In spite development conventional therapeutics including surgery, chemotherapy, radiotherapy immunotherapy, treatment these still challenging. As a result, new based on (nano)biotechnology have been introduced. Hydrogels polymeric 3D networks capable absorbing water swell with favorable biocompatibility. application hydrogels different human diseases, wide cancer has improved because potential drug gene delivery, boosting chemotherapy immunotherapy as well vaccines. The current review focuses role gastrointestinal tumors. provide delivery drugs (both natural or synthetic compounds co-delivery) along delivery. Along stimulate phototherapy (photothermal photodynamic therapy) suppression Besides, ability for induction immune-related cells such dendritic can boost immunotherapy. For more specific therapy, stimuli-responsive types thermo- pH-sensitive self-healing site Moreover, promising diagnosis, circulating tumor cell isolation detection biomarkers tumors, highlighting importance clinic. Hence, diagnostic therapeutic tools gastrointestimal
Language: Английский
Citations
2Biomaterials Science, Journal Year: 2024, Volume and Issue: 12(23), P. 6082 - 6098
Published: Jan. 1, 2024
Radiofrequency ablation (RFA) is a commonly used minimally invasive treatment for hepatocellular carcinoma (HCC). However, incomplete radiofrequency (iRFA) promotes tumor progression and metastasis. There an urgent need to develop innovative strategies enhance the efficacy of iRFA. The upregulation heat shock proteins (HSPs) activation protective autophagy in cells upon exposure sublethal thermotolerance, thereby promoting cell survival. Here, 3-methyladenine (3-MA) lonidamine (LND) co-encapsulated liposomes (Lip@LND/3-MA) are designed iRFA by simultaneous inhibition glycolysis autophagy. On one hand, LND inhibits hexokinase, key enzyme glycolysis, thus reduces ATP production consequently suppresses expression HSPs. other 3-MA, as inhibitor, can inhibit after Lip@LND/3-MA confirmed suppress HSPs reduce level during RFA. Therefore, thermotolerance significantly weakened, leading remarkably enhanced therapeutic It believed that promising strategy clinical practice
Language: Английский
Citations
1Chinese Chemical Letters, Journal Year: 2024, Volume and Issue: unknown, P. 110569 - 110569
Published: Oct. 1, 2024
Language: Английский
Citations
1Biomaterials Advances, Journal Year: 2024, Volume and Issue: 169, P. 214158 - 214158
Published: Dec. 20, 2024
Language: Английский
Citations
1